Peer Review History
| Original SubmissionJuly 8, 2025 |
|---|
|
Dear Dr. Vittum, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process. Please submit your revised manuscript by Oct 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mária A. Deli, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 3. Thank you for stating the following in the Competing Interests section: “This work was funded by startup funding awarded to Prof. Mensah by Worcester Polytechnic Institute. The authors have declared that no competing interests exist.” Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Two experts have evaluated the manuscript. They agreed it has merits but further amendments are needed. Please complete the asked methodological parts, and the discussion. Further lectin staining is suggested to get more data on glycan diversity behind the observed changes. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Summary: This manuscript presents a study of apical and basal glycocalyx expression in human lung microvascular endothelial cells (HLMVECs) under varying fluid shear stress conditions. The authors explore temporal changes in glycocalyx coverage, intensity, and thickness across a range of physiologically and pathophysiologically relevant fluid shear stress magnitudes. The work is timely and contributes meaningfully to our understanding of endothelial mechanobiology. Strengths 1. The study includes multiple fluid shear stress magnitudes and time points (0 hr, 30 min, 12 hr), allowing for dynamic interpretation of glycocalyx behavior. 2. The focus on both apical and basal glycocalyx responses is valuable, especially the suggestion that basal glycocalyx may be sensitive to apical fluid shear stress. 3. The findings under very low fluid shear stress conditions may have important implications for vascular pathologies and warrant further exploration. Weaknesses & Suggestions for Improvement 1. Cover Sheet Inconsistencies: 1.1. The funding disclosure states no support was received, yet institutional funding is mentioned in the manuscript. This should be corrected to ensure proper acknowledgment. 1.2. The data availability statement includes a minor typographical error: “analyzed the presented” likely should read “analyzed and presented.” 2. Introduction Clarity: 2.1. The mention of turbulence is vague. Does turbulent flow occur in the body, and under what conditions? Clarifying this would strengthen the physiological relevance. 2.2. The hypothesis is not explicitly stated. A clear hypothesis would help frame the study and guide interpretation of the results. 3. Methods Presentation: 3.1. Supplemental Figure 3 could be in the main body of the paper 4. Results Presentation: 4.1. The emphasis on permeabilization vs. non-permeabilization is confusing given that glycocalyx is extracellular. The rationale for this distinction should be clarified. 4.2. Figures 2 to 5 do not indicate whether cells were permeabilized. 4.3. In Figure 1, statistical comparisons across time points are missing. Given the observed decrease at 30 min and recovery at 12 hr, statistical analysis would strengthen the conclusions. 4.4. Supplemental figure data appear inconsistent with the purple bars in Figure 1, though both are said to represent non-permeabilized cells. This discrepancy should be explained. 5. Discussion Gaps: 5.1. There is a statement made that glycocalyx returns to baseline after 12 hr. The data shows 12 hr fluid shear stress leads to glycocalyx levels matching or falling below static conditions, depending on specific shear stress magnitude. This contradicts the expectation that fluid shear stress promotes glycocalyx growth and should be addressed. 5.2. The authors should elaborate on the implications of the finding that very low fluid shear stress drives a decrease in glycocalyx coverage and intensity over time, as this has important disease relevance. 5.3. The conclusion that basal glycocalyx is sensitive to apical fluid shear stress is intriguing but underexplored. The authors should expand on possible mechanisms and significance. 5.4. The observation that differences between fluid shear stress magnitudes only emerge at 12 hours (Figure 5) suggests short-term studies may be inadequate for HLMVECs. This point deserves more emphasis in the discussion. 6. Goal vs. Interpretation Misalignment: 6.1. The results are heavily focused on permeabilization status, which does not clearly align with the stated goal of examining glycocalyx expression. The authors should clarify why this distinction is central to their analysis. 6.2. Several findings appear to reconfirm prior published work. The authors should clarify what is novel in their observations and how their data extend or challenge existing literature. Reviewer #2: The work submitted to PLOS One by Vittum & Mensah et al., entitled: “Fluid shear stress-dependent modulation of the basal endothelial glycocalyx.” Provides an innovative approach to measuring the glycocalyx composition on both sides of endothelial cells under various flow conditions. The authors provide an innovative method for measuring glycocalyx thickness in an endothelial cell culture system exposed to various flow conditions. The main issue with the manuscript is the lack of detail in the methods section. More specifically, the manuscript lacks enough references for the design and rationale. In its current form, the manuscript is not suitable for publication. The authors can respond to the comments below for future consideration. The issues mentioned above, as well as additional major and minor concerns, are outlined below: Major: 1. The manuscript lacks sufficient details in the methodology, for example: Line 348: Need source for 3-4 days being sufficient for full maturation of GCX on HLMVECs Line 364 Please provide source which shows that WGA binds to ‘all lectins of the GCX’ Line 346 Can the authors elaborate on why media that is optimized for breast tissue is being used for lung endothelial cells? Line 365 the use of streptavidin is confusing, as it is unclear where biotin is used in the methods Line 389 The authors state that: “Background intensity was determined to be the intensity that corresponds to 6% of the normalized distribution of pixel intensities in the apical GCX and 8% in the basal GCX for each experimental group” Can the authors elaborate on how these 6 and 8 % values were determined. 2. The manuscript lacks depth as the same assessments were done across different conditions and turned into separate figures. The different FSS rates could be combined into a single figure. This would leave room for figures that focus on specific glycan changes under FSS conditions. 3. The manuscript could benefit from the addition of a lectin with specificity to a particular glycan component of the GCX (e.g., hyaluronan, or heparan sulfates). The use of a Pan-GCX marker does imply the change, but the mechanism of those changes could be parsed out with more specific markers for GCX components. This was mentioned on line 334, but at least some data should be presented showing specific changes in a particular glycan after FSS. 4. In the Introduction (line 43) and in the discussion, there are mentions of heparan sulfates and syndecan-1. These markers could have been assessed in this model system using validated probes for their expression. 5. Can the authors elaborate on how changes in cell polarity (i.e., movement of the nucleus, as demarcated by DAPI) could influence their interpretation of Apical vs. Basal surfaces under different flow conditions? Minor: Line 225: The use of the term peptides here seems vague. Please be more specific in the discussion. Line 363 Should Wheat germ albumin be ‘agglutinin’? Line 360 Bovine serum albumin (BSA) needs to be defined earlier Figure legends should be placed at the end of the manuscript on initial submission, rather than embedded in the results section. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Vittum, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mária A. Deli, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have been responsive to both sets of reviewer comments, and the revisions have substantially improved the manuscript. Most of the weaknesses noted in the initial review have been addressed, which is commendable. Two minor concerns remain: Figures 2–5: The figure legends do not clearly indicate whether the cells were permeabilized. If this information is already included, it should be made explicit in the legends or methods section for clarity. Figure 1: Statistical comparisons across time points are still missing. Given the observed decrease at 30 minutes and recovery at 12 hours, statistical analysis would strengthen the conclusions. In particular, for panels H and I, statistical analysis across time points appears feasible unless the authors consider it unnecessary due to the detailed data presented in Figures 2–4. If so, a brief clarification would be helpful. Overall, the manuscript is much improved, and addressing these final points will further enhance clarity and rigor. Reviewer #2: The authors have adequately addressed reviewer comments. The manuscript is much improved and suitable for publication ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Aric F. Logsdon ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Fluid shear stress-dependent modulation of the basal endothelial glycocalyx PONE-D-25-37102R2 Dear Dr. Vittum, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mária A. Deli, M.D., Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Previous critique #1 has been satisfactorily addressed. Regarding critique #2 (“Figure 1: Statistical comparisons across time points are still missing”), this point was not directly addressed in the revision. However, this is a minor concern since the necessary comparisons across time points are demonstrated in other figures within the manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-37102R2 PLOS One Dear Dr. Vittum, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Mária A. Deli Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .